Teladoc Health

Cybersecurity Engineer III

Teladoc Health
Apply
1 day ago

Base Salary

$149k - $171k/yr

Responsibilities

  • Integrate Static Application Security Testing, Software Composition Analysis, and secrets-scanning tools into development workflows.
  • Write basic scripts to automate security checks and monitor vulnerabilities within the software development lifecycle.
  • Monitor Endpoint Detection and Response alerts and ensure application controls and threat detection are correctly applied across Teladoc Health’s medical device fleet.
  • Assist with medical device security risk assessments and enforce security controls.
  • Document compliance with safety standards and provide clear documentation for security controls and processes.
  • Translate security findings into actionable engineering guidance and collaborate with DevOps and application teams on security solutions.

Requirements

  • Bachelor’s degree or foreign equivalent in Computer Science, Information Technology, Electrical Engineering, Cybersecurity, Computer Engineering, or a related field.
  • Four years of experience as a Cybersecurity Engineer, Security Analyst, or in an occupation involving application security and medical device security within the healthcare industry.
  • Employment experience with AppSec, DevSecOps, EDR, security-control implementation in medical device systems, cross-functional security solutions, and security documentation.

Benefits

  • 100% telecommuting.
  • Flexible Vacation Policy, with manager approval required for time off.
  • 80 hours of paid sick, safe, and caregiver leave annually for full-time positions.

Categories

Teladoc Health

About Teladoc Health

5,001-10,000 employees

Teladoc Health builds a virtual-care platform delivering primary, urgent, mental-health, and chronic-condition services via web and mobile, sold to employers, health plans, hospitals, and health systems. Its business model combines per‑member subscriptions with visit-based fees, supported by clinical networks and EMR integrations. The New York–based company is publicly traded on the NYSE and expanded its chronic-care capabilities by acquiring Livongo in 2020.

Contact me